ANTX short interest
AN2 Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,491,971 |
|---|---|
| Change vs prior report | 94,664 (+4.0%) |
| Change over six months | +341.6% |
| Days to cover | 9.54 (sector: 3.78) |
| Average daily volume | 261,160 |
| Rank in Healthcare | #125 of 922 by days to cover |
ANTX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,491,971 | +4.0% | 9.54 | 261,160 |
| 2026-09-15 | 2,397,307 | -4.4% | 11.79 | 203,314 |
| 2026-08-31 | 2,507,571 | +12.8% | 11.53 | 217,471 |
| 2026-08-14 | 2,223,166 | -6.5% | 10.12 | 219,629 |
| 2026-07-31 | 2,377,829 | -2.4% | 14.75 | 161,159 |
| 2026-07-15 | 2,435,644 | +26.6% | 9.90 | 246,030 |
| 2026-06-30 | 1,923,757 | +47.3% | 2.87 | 670,298 |
| 2026-06-15 | 1,305,874 | +8.2% | 6.91 | 188,877 |
| 2026-05-29 | 1,207,503 | +44.4% | 5.39 | 223,905 |
| 2026-05-15 | 836,372 | -4.9% | 3.47 | 240,708 |
| 2026-04-30 | 879,488 | +38.7% | 3.31 | 265,395 |
| 2026-04-15 | 633,935 | +12.3% | 1.52 | 416,717 |
| 2026-03-31 | 564,275 | -20.7% | 1.39 | 404,664 |
| 2026-03-13 | 711,585 | +1122.5% | 1.00 | 7,411,726 |
| 2026-02-27 | 58,207 | +9.5% | 1.00 | 85,374 |
| 2026-02-13 | 53,144 | +1.1% | 1.00 | 57,059 |
| 2026-01-30 | 52,574 | +5.2% | 1.00 | 73,228 |
| 2026-01-15 | 50,000 | +11.4% | 1.00 | 188,023 |
| 2025-12-31 | 44,898 | +8.6% | 1.00 | 44,696 |
| 2025-12-15 | 41,353 | +10.0% | 1.00 | 71,635 |
| 2025-11-28 | 37,586 | -20.9% | 1.00 | 44,908 |
| 2025-11-14 | 47,530 | +24.6% | 1.00 | 103,718 |
| 2025-10-31 | 38,130 | -6.3% | 1.00 | 80,816 |
| 2025-10-15 | 40,679 | -40.1% | 1.00 | 46,215 |
| 2025-09-30 | 67,864 | +15.5% | 1.00 | 79,866 |
import finzdata as yf
yf.Ticker("ANTX").short_interest # every report since 2017
yf.Client().short_interest(["ANTX"], start="2018-01-01")Healthcare short interest · ANTX price history · Who owns ANTX · All short interest